Eversept Partners, LP

Position in ASND — Ascendis Pharma A/S

CIK 1697013 NEW YORK, NY

Position in ASND

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$11,101,153

+$814,243 QoQ

Shares Held

41,621

-13.7% QoQ

Ownership

0.063%

of shares outstanding

% of Portfolio

0.61%

of 13F equity value

Holder Rank

#92

of 307 holders

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Eversept Partners, LP holds $859,319,346 across 72 Biotechnology names. ASND ranks #19 (1.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A.	913,880	$121,783,648
2	VERA	Vera Therapeutics, Inc.	2,212,770	$94,949,960
3	CLDX	Celldex Therapeutics, Inc.	1,785,941	$66,454,864
4	SNDX	Syndax Pharmaceuticals Inc	2,798,210	$61,168,870
5	IONS	Ionis Pharmaceuticals Inc	664,684	$52,702,794
6	TVTX	Travere Therapeutics, Inc.	798,973	$45,389,656
7	PCVX	Vaxcyte, Inc.	629,952	$36,619,109
8	GERN	Geron Corp	18,717,422	$23,958,300

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$11,101,153	41,621	-13.7%	Shares	Sole	2026-08-14
2025-12-31	$10,286,910	48,241	-88.4%	Shares	Sole	2026-02-17
2022-03-31	$48,959,305	417,172	+3.3%	Shares	Sole	2023-11-08
2021-12-31	$54,306,801	403,678	-9.3%	Shares	Sole	2023-11-08
2021-09-30	$70,960,906	445,203	+84.1%	Shares	Sole	2023-11-08
2021-06-30	$31,805,369	241,774	-22.5%	Shares	Sole	2023-11-08
2021-03-31	$40,193,418	311,867	+66.7%	Shares	Sole	2023-11-08
2020-12-31	$31,195,031	187,043	+16.2%	Shares	Sole	2023-11-08
2020-09-30	$24,846,137	161,004	-26.9%	Shares	Sole	2023-11-08
2020-06-30	$32,588,877	220,344	-20.0%	Shares	Sole	2023-11-08
2020-03-31	$31,023,379	275,494	—	Shares	Sole	2023-11-08
No filing history on record for this holder in this stock.